HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What is the Talisman Study? What is the Waterless Empirical Taste Test?

Posted by
HealthTree Logo HealthTree
• June 15, 2026

Description

What is the Talisman Study? What is the Waterless Empirical Taste Test?

On this video

Healthtree contact Samantha Shenoy, NP

Samantha Shenoy, NP

Healthtree contact Ajai Chari, MD

Ajai Chari, MD

Related Content

  • News Does Everyone Diagnosed with Multiple Myeloma Need A Stem Cell Transplant?
  • Event Monthly Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions
  • News Can Mezigdomide Help Elranatamab Work Better? Early Results From the MELT-MM Trial
  • Podcast Answering the Transplant Question for Newly Diagnosed Patients - The FASTER Study
  • Video Etentamig in Heavily Pretreated Myeloma: Phase 3 CERVINO Results | IMS 2026 #myeloma
  • Video BCMA Bispecifics in Myeloma: Do Real-World Results Match Clinical Trials? | IMS 2026